An exploratory analysis of the association between EORTC QLQ-C30 domains and the progression-free/overall survival in advanced melanoma after 12 weeks of treatment on ipilimumab compared to gp100 in a phase III clinical trial

Authors:

Lee D, Harvey B, Gaudin A-F, Gueron B, Bregman B, Lebbé C, Bonnetain F, Borget I.

Publication Type:

Conference Proceedings – Poster

Publication Name:

16th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Lee D, Harvey B, Gaudin A-F, Gueron B, Bregman B, Lebbé C, Bonnetain F and Borget I. An exploratory analysis of the association between EORTC QLQ-C30 domains and the progression-free/overall survival in advanced melanoma after 12 weeks of treatment on ipilimumab compared to gp100 in a phase III clinical trial. 16th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Dublin, Ireland. 2-6 November. Poster PCN170.


Link to publication ⟶

⟵ Back to Search Results